News | RIVM

Lareb notes newly reported deaths shortly after vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.

New research in GGD test lanes on spread of coronavirus SARS-CoV-2

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.

80 to 84-year-olds invited for vaccination sooner

Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.

Man receives COVID-19 vaccination at GGD vaccination site

One person died shortly after COVID-19 vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

Nationwide assessment of SARS-CoV-2 laboratories: very high quality

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.

Brazilian coronavirus variants (P1 and P2) found in the Netherlands

Two new variants of the coronavirus SARS-CoV-2 have been found in the Netherlands, both originating from Brazil.

Invitation letter for COVID-19 vaccination for people aged 85-89 years arriving today

Today, the first 50,000 people in the age group from 85-89 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.

COVID-19 vaccination resident nursing home 18 January 2021

Last winter’s flu epidemic was short and mild. And then COVID-19 arrived.

The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.

De griepepidemie in de winter van 2019/2020 was mild en duurde slechts 5 weken.

COVID-19 vaccinations for first residents of nursing homes and small-scale residential facilities

Today, the first COVID-19 vaccines will be administered to residents of nursing homes and care facilities for people with intellectual disabilities in the Netherlands.

South African coronavirus variant found in the Netherlands

The South African variant of the coronavirus (501Y.V2) has been identified in the Netherlands for the first time.